# Five Star Bancorp: financial statements, quarterly

FSBC · Nasdaq · CIK 1275168 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsbc.md) · [Financials](/companies/fsbc/financials.md) · [Filings](/companies/fsbc/filings.md) · [Insiders](/companies/fsbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [17.6](/filings/0001275168-23-000132.md) | [19.5 d](/filings/0001275168-24-000061.md) | [20.8](/filings/0001275168-24-000094.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.8](/filings/0001275168-24-000140.md) | [4.4 d](/filings/0001628280-26-012724.md) | [4.3](/filings/0001275168-25-000106.md) | [4.4](/filings/0001628280-25-038796.md) | [4.3](/filings/0001628280-25-050090.md) | [6.1 d](/filings/0001628280-26-012724.md) | [5.3](/filings/0001628280-26-032282.md) | [5.6](/filings/0001628280-26-054141.md) | [5.9](/filings/0001628280-25-050090.md) | [5.4 d](/filings/0001628280-26-012724.md) | [6.4](/filings/0001628280-26-032282.md) | [6.7](/filings/0001628280-26-054141.md) |
| Net income | $m | [11.0](/filings/0001275168-24-000140.md) | [10.8 d](/filings/0001628280-26-012724.md) | [10.6](/filings/0001275168-25-000106.md) | [10.8](/filings/0001628280-25-038796.md) | [10.9](/filings/0001628280-25-050090.md) | [13.3 d](/filings/0001628280-26-012724.md) | [13.1](/filings/0001628280-26-032282.md) | [14.5](/filings/0001628280-26-054141.md) | [16.3](/filings/0001628280-25-050090.md) | [17.6 d](/filings/0001628280-26-012724.md) | [18.6](/filings/0001628280-26-032282.md) | [19.4](/filings/0001628280-26-054141.md) |
| Diluted EPS | $ per share | [0.64](/filings/0001275168-24-000140.md) | not reported | [0.62](/filings/0001275168-25-000106.md) | [0.51](/filings/0001628280-25-038796.md) | [0.52](/filings/0001628280-25-050090.md) | not reported | [0.62](/filings/0001628280-26-032282.md) | [0.68](/filings/0001628280-26-054141.md) | [0.77](/filings/0001628280-25-050090.md) | not reported | [0.87](/filings/0001628280-26-032282.md) | [0.91](/filings/0001628280-26-054141.md) |
| Basic EPS | $ per share | [0.64](/filings/0001275168-24-000140.md) | not reported | [0.62](/filings/0001275168-25-000106.md) | [0.51](/filings/0001628280-25-038796.md) | [0.52](/filings/0001628280-25-050090.md) | not reported | [0.62](/filings/0001628280-26-032282.md) | [0.68](/filings/0001628280-26-054141.md) | [0.77](/filings/0001628280-25-050090.md) | not reported | [0.87](/filings/0001628280-26-032282.md) | [0.91](/filings/0001628280-26-054141.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,505](/filings/0001275168-23-000132.md) | [3,593](/filings/0001275168-25-000038.md) | [3,476](/filings/0001275168-24-000094.md) | [3,634](/filings/0001275168-24-000112.md) | [3,887](/filings/0001275168-24-000140.md) | [4,053](/filings/0001628280-26-012724.md) | [4,245](/filings/0001275168-25-000106.md) | [4,413](/filings/0001628280-25-038796.md) | [4,642](/filings/0001628280-25-050090.md) | [4,755](/filings/0001628280-26-054141.md) | [5,032](/filings/0001628280-26-032282.md) | [5,377](/filings/0001628280-26-054141.md) |
| Total liabilities | $m | [3,231](/filings/0001275168-23-000132.md) | [3,307](/filings/0001275168-25-000038.md) | [3,184](/filings/0001275168-24-000094.md) | [3,254](/filings/0001275168-24-000112.md) | [3,497](/filings/0001275168-24-000140.md) | [3,657](/filings/0001628280-26-012724.md) | [3,839](/filings/0001275168-25-000106.md) | [3,997](/filings/0001628280-25-038796.md) | [4,210](/filings/0001628280-25-050090.md) | [4,309](/filings/0001628280-26-054141.md) | [4,573](/filings/0001628280-26-032282.md) | [4,903](/filings/0001628280-26-054141.md) |
| Shareholders' equity | $m | [274](/filings/0001275168-24-000140.md) | [286](/filings/0001628280-26-012724.md) | [293](/filings/0001628280-25-038796.md) | [380](/filings/0001628280-25-050090.md) | [390](/filings/0001628280-25-050090.md) | [397](/filings/0001628280-26-054141.md) | [406](/filings/0001628280-26-054141.md) | [417](/filings/0001628280-26-054141.md) | [431](/filings/0001628280-25-050090.md) | [446](/filings/0001628280-26-054141.md) | [459](/filings/0001628280-26-054141.md) | [474](/filings/0001628280-26-054141.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.9 d](/filings/0001275168-24-000140.md) | [(1.6) d](/filings/0001628280-26-012724.md) | [0.2](/filings/0001275168-25-000106.md) | [16.0 d](/filings/0001628280-25-038796.md) | [17.5 d](/filings/0001628280-25-050090.md) | [18.0 d](/filings/0001628280-26-012724.md) | [15.5](/filings/0001628280-26-032282.md) | [17.8 d](/filings/0001628280-26-054141.md) | [18.8 d](/filings/0001628280-25-050090.md) | [20.6 d](/filings/0001628280-26-012724.md) | [18.9](/filings/0001628280-26-032282.md) | [23.7 d](/filings/0001628280-26-054141.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001275168-24-000140.md) | [0.2 d](/filings/0001628280-26-012724.md) | [0.1](/filings/0001275168-25-000106.md) | [0.2 d](/filings/0001628280-25-038796.md) | [0.2 d](/filings/0001628280-25-050090.md) | [0.1 d](/filings/0001628280-26-012724.md) | [0.1](/filings/0001628280-26-032282.md) | [0.2 d](/filings/0001628280-26-054141.md) | [0.2 d](/filings/0001628280-25-050090.md) | [0.6 d](/filings/0001628280-26-012724.md) | [0.2](/filings/0001628280-26-032282.md) | [0.4 d](/filings/0001628280-26-054141.md) |
| Dividends paid | $m | [3.5 d](/filings/0001275168-24-000140.md) | [3.5 d](/filings/0001628280-26-012724.md) | [3.5](/filings/0001275168-25-000106.md) | [4.3 d](/filings/0001628280-25-038796.md) | [4.3 d](/filings/0001628280-25-050090.md) | [4.3 d](/filings/0001628280-26-012724.md) | [4.3](/filings/0001628280-26-032282.md) | [4.3 d](/filings/0001628280-26-054141.md) | [4.3 d](/filings/0001628280-25-050090.md) | [4.3 d](/filings/0001628280-26-012724.md) | [5.3](/filings/0001628280-26-032282.md) | [5.3 d](/filings/0001628280-26-054141.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.2](/filings/0001275168-23-000132.md) | [17.2](/filings/0001275168-24-000094.md) | [17.2](/filings/0001275168-24-000112.md) | [17.2](/filings/0001275168-24-000140.md) | [17.3](/filings/0001275168-25-000106.md) | [21.1](/filings/0001628280-25-038796.md) | [21.2](/filings/0001628280-25-050090.md) | [21.3](/filings/0001628280-26-032282.md) | [21.3](/filings/0001628280-26-054141.md) | [21.3](/filings/0001628280-25-050090.md) | [21.3](/filings/0001628280-26-032282.md) | [21.3](/filings/0001628280-26-054141.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,536,614 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054141.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.